CTRI/2026/03/105658尚未招募2 期
AN OPEN LABELLED NON RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFECTIVENESS OF THOKKANAM [ PIDITHAL AND AZHUTTHAL MURAI ] USING NALVELAI VATHA ENNAI (EXTERNAL) IN THE MANAGEMENT OF THANDAGA VATHAM [ LUMBAR SPONDYLOSIS ].
DR ARPITA BISWAS S1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年3月20日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
It is an open labelled non randomized phase II clinical trial to evaluate the efficacy of
Trial drug :
NALVELAI VATHA ENNAI ( external medicated oil )
External therapy:
Thokkanam
The 4 types of oil is taken in equal quantity and mixed . Then extract of nalvelai and goat milk is added in required quantity. This mixture is boiled till it attains suitable consistency.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Participants having symptoms of pain in the lumbar region.
- •Participants having radiating pain to gluteal and lower limbs.
- •Participants having stiffness/ muscle spasm present in lumbar region.
- •Participants having pain during forward bending of spine.
- •Participants with or without numbness and burning sensation in lower limbs.
- •Participants with positive signs for the specific lumbar examinations.
- •Participants who are willing to attend OPD and admission and stay in IPD.
- •Positive radiological findings (X ray/CT/MRI) for lumbar spondylosis.
- •Participants with mild to moderate grade of symptoms.
排除标准
- •Participants with recent H/O trauma, fracture, dislocation and surgery.
- •Participants with H/O cardiac diseases.
- •Participants with severe disc bulge, disc protrusion, disc herniation and disc sequestration.
- •Autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus, psoriasis, mixed connective tissue disorders.
- •Ankylosing spondylitis, Tuberculosis of lumbar spine, cauda equina syndrome, osteomyelitis etc.
- •Spina bifida and any other deformity of vertebral spine.
- •Renal calculi.
- •Pregnancy and lactating women.
- •Any other serious illness like any other skin disease and skin infection Participants who need internal medicines.
研究者
DR ARPITA BISWAS S
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL , PALAYAMKOTTAI
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFECTIVENESS OF VENNOCHI POTTANAM (EXTERNAL - MEDICATED POUCH) IN THE MANAGEMENT OF SETHTHUMA THALAINOKKADU [PRIMARY CEPHALGIA]CTRI/2026/02/104679DR JANANI E40
已完成
2 期
An open lab effectiveness of Effectiveness of KOWSIGAR KULAMBU PUGAI[EXTERNAL THERAPY] in the management of VELI MOOLAM[EXTERNAL HAEMORRHOID]CTRI/2024/06/068356Dr S Dheivani40
招募中
2 期
A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLCNCT07264816Sichuan Baili Pharmaceutical Co., Ltd.80
已完成
2 期
An open labelled non randomized phase II clinical trial to evaluate the effectiveness of kalvaazhai kattu (Bandage in siddha external therapy) in the management of Azhal keel vayuCTRI/2024/05/067408Dr R Anand40
招募中
2 期
A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)Esophageal Squamous Cell CarcinomaNCT07554456Sichuan Baili Pharmaceutical Co., Ltd.90